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Background/introduction
Severe chronic peripheral arterial disease (PAD) mani-
fests as critical limb ischemia (CLI) with a 5-year mor-
tality rate >70%. Mesenchymal stem cells (MSC) show
promise to minimize CLI progression and restore perfu-
sion in experimental models, but approaches suffer from
minimal homing to ischemic tissue and require clinically
impractical direct injections of cells. We show that
pulsed focused ultrasound (pFUS) noninvasively estab-
lishes a “molecular zip-code” of locally upregulated che-
moattractants (i.e. cytokines, chemokines, cell adhesion
molecules) that lead to enhanced homing permeability
and retention of IV-infused MSC to pFUS-treated mus-
cle. This study investigated if pFUS could enhance MSC
homing in a CLI model in aged mice and whether they
could ultimately improve limb perfusion.
Methods
CLI was induced by ligating the external iliac artery in
C3H mice (9-12 months old). At 14 days post-CLI, mice
were grouped as followed: saline controls (n=8); pFUS
alone (n=7), MSC alone (n=8), or MSC+pFUS (n=17).
Mice were treated, according to their group, daily for
3 days (i.e, 3×pFUS, 3×MSC, 3×MSC+pFUS). pFUS was
applied to ischemic hamstrings at 40W (5% duty cycle,
5Hz PRF, 100 pulses). For mice receiving MSC, 106
MSC were IV injected via the lateral tail vein. Mice
receiving pFUS+MSC had MSC injected ~1hr pre-pFUS.
To assess MSC homing, mice were euthanized at
15 days post-CLI (24 hr after last treatment). Fe-labeled
MSC were counted by microscopy after Prussian Blue
staining. Laser Doppler perfusion imaging (LDPI) was
performed weekly for 7-8 weeks post-treatment.
Results and conclusions
Results: Significantly more MSC homed to pFUS-treated
ischemic hamstrings than ischemic hamstrings without
pFUS (p<0.01) or normal hamstrings (Fig 1). LDPI
revealed that restoration of limb perfusion was signifi-
cantly greater in the pFUS+MSC mice beginning 2
weeks post-treatment (4 weeks post-ischemia) (Fig 2).
Limb perfusion in the pFUS+MSC group continued to
improve for the remainder of the study (7 weeks post-
ischemia), while groups treated with MSC alone, pFUS
alone, or saline remained near baseline perfusions levels.
Conclusion: pFUS-enhanced MSC homing is a clinically
relevant modality with potential to treat PAD. Previous
1National Institutes of Health, Bethesda, Maryland, United States
Full list of author information is available at the end of the article
Figure 1 14 days post-CLI, mice were given either MSC alone or
pFUS+MSC and hamstrings were harvested 24 hrs. MSC failed to
home to ischemic limbs without pFUS, but significantly more
(p<0.05) MSC homed to ischemic limbs when they were treated
with pFUS.
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experimental CLI studies have shown promise, but they
inadequately model clinical PAD. They utilize direct cell
injections into ischemic muscle, administer cells immedi-
ately after injury, and use young animals with robust heal-
ing capabilities. We show that when treatment is delayed
(14 days post-CLI, during sub-acute inflammation) in aged
mice, iv-injected MSC largely fail to home to ischemic
muscle and have limited therapeutic potential. However,
pFUS can noninvasively establish a molecular zip-code of
upregulated chemoattractants to enhance MSC homing
where therapeutic MSC can help restore perfusion to
ischemic limbs. As direct injections are impractical clini-
cally, systemic MSC delivery is necessary and pFUS gui-
dance of MSC may be critical to develop effective cell
therapies in PAD.
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Figure 2 14 days after CLI induction mice received 3 consecutive days of pFUS, MSC, or MSC+pFUS. At 2 weeks post treatment significant
increase (p<0.05) in laser Doppler blood flow compared to 3XpFUS, 3XMSC, and saline group.
Tebebi et al. Journal of Therapeutic Ultrasound 2015, 3(Suppl 1):P105
http://www.jtultrasound.com/content/3/S1/P105
Page 2 of 2
